Thermo Fisher buys Solventum’s purification business for $4.1Bnews2025-02-25T17:13:34+00:00February 25th, 2025|Endpoints News|
Indian drugmakers join forces to boost national biomanufacturing sector news2025-02-25T15:50:33+00:00February 25th, 2025|Endpoints News|
Hims eyes growth in its weight loss business, despite end of semaglutide shortagenews2025-02-25T14:30:53+00:00February 25th, 2025|Endpoints News|
BridGene nets another Takeda deal amid plans to raise more funding and go publicnews2025-02-25T13:00:10+00:00February 25th, 2025|Endpoints News|
Eli Lilly expands Zepbound single-dose vial options at lower pricenews2025-02-25T11:45:31+00:00February 25th, 2025|Endpoints News|
Pfizer hires former top FDA deputy Patrizia Cavazzoni as CMOnews2025-02-24T15:20:01+00:00February 24th, 2025|Endpoints News|
Amgen plans further $200M investment in new tech facility in Indianews2025-02-24T14:55:48+00:00February 24th, 2025|Endpoints News|
Pfizer wants in on Summit’s goal to beat Keytruda via ADC combosnews2025-02-24T12:18:40+00:00February 24th, 2025|Endpoints News|
Post-Hoc: Pharma CEOs’ alternative reality with Trumpnews2025-02-22T14:15:29+00:00February 22nd, 2025|Endpoints News|
Teva launches Stelara biosimilar at 85% discount as wider field emergesnews2025-02-21T17:17:47+00:00February 21st, 2025|Endpoints News|
